Roche's Virtual Pipeline Event on data presented at IASLC World Conference on Lung Cancer
Agenda:
Roche lung cancer portfolio key data
Roche Lung Cancer program overview
Q&A
IMpower133: Primary PFS, OS, and Safety in a Ph1/3 Study of 1L Atezolizumab + Carboplatin + Etoposide in extensive-stage SCLC
IMpower132: PFS, OS and Safety Results of 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC
Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive NSCLC

Please register to access the replay*

*Privacy notice

Live webinar

Roche has hosted a live video webcast and conference call on Tuesday, 25 September 2018.

Investors
Past IR Events
View more Events

Downloads

Related links